Top alert for 2014: MYGN (50%), LIVE (45%), CTIC (115%), KOOL (88%), PZG (32%), GOLD (6%), IOC (6%), RSOL(18%), PLUG (70%), IMMU (26%)

Monday, August 25, 2014

Day Trade Watchlist for August 25th: QIHU, BKW, THI, ARWR, LTM, HAS, INSY, ALKS, VVUS, XGTI, GMCR, SHLD, FN, SPEX, ANN

Trade Plan:
QIHU (S and L), ARWR (L ), GME (S ), CSCO (S ), YNDX (L), GMCR (S), HAS (L ), TRP (L @51.35), SHLD S, FN L , BKW , THI , LTM (L and S later)

News that matter:

Wachout for $KANG, $BWS, $CLR, $FPF.

wachout for $KERX, $ILMN,$PLNR, AND $WHX


watchout $AINV, $DGLY,$DEM.


$BKW has moved from 32.84 to 33.43 in 10 minutes.

XGTI gets $5 Pt

Life Time Fitness Announces Exploration of REIT Conversion $LTM

Roche to buy InterMune for $8.3B in cash i.e $74 per share (ITMN)

Occidental Petroleum in talks to sell $3B gas stake to Mubadala (OXY)
Hasbro (HAS) looks like a more attractive stock to own than Mattel (NASDAQ:MAT) with EPS moving in the right direction and shares paying out a healthy 3.3% dividend yield, according to Barron's Jack Hough.

Qihoo 360 reports adjusted Q2 EPS 50c, consensus 46c, sees Q3 revenue $360M-$365M, consensus $357.39M QIHU

Advaxis and Merck (MRK) form collaboration to evaluate investigational combination of two novel immunotherapy candidates for advanced prostate cancer (ADXS)

Insys Therapeutics receives orphan drug designation for its pharmaceutical cannabidiol (CBD) for the treatment of glioblastoma multiforme (INSY) 

Alkermes announces submission of NDA for aripiprazole lauroxil for the treatment of schizophrenia (ALKS)

Spherix: first trial of Nortel patents since bankruptcy scheduled against Verizon (VZ) for 1Q2015; Federal Circuit issues scheduling order in litigation against Verizon (SPEX)  Sept 12, Dec 10, Dec 18th important date.

Vivus announced the acquisition of a group of patents from Janssen Pharmaceuticals (JNJ) covering uses of topiramate as monotherapy (VVUS)

ANN: Engine Capital and Red Alder deliver letter to ANN Board; 'we urge the Board to retain immediately a nationally-recognized investment bank and establish a special committee of independent directors to explore strategic alternatives to maximize shareholder value, including a sale of the co' (ANN)

Regado Biosciences permanently halts REGULATE-PCI clinical trial (RGDO)



Closed Position:
Plan and execute:
Don't follow this trade. This are closed. Stock could have moved significantly from closed position.

DGLY Long:

LTM Short:

No comments:

Post a Comment